The prognostic value of cytogenetics is reinforced by the kind of induction/consolidation therapy in influencing the outcome of acute myeloid leukemia--analysis of 848 patients. [electronic resource]
Producer: 20010712Description: 903-9 p. digitalISSN:- 0887-6924
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Chromosome Aberrations
- Chromosome Deletion
- Chromosome Inversion
- Chromosomes, Human -- ultrastructure
- Combined Modality Therapy
- Cytarabine -- administration & dosage
- Daunorubicin -- administration & dosage
- Disease-Free Survival
- Etoposide -- administration & dosage
- Female
- Hematopoietic Stem Cell Transplantation
- Hepatomegaly -- epidemiology
- Humans
- Idarubicin -- administration & dosage
- Karyotyping
- Leukemia, Myeloid -- drug therapy
- Male
- Middle Aged
- Mitoxantrone -- administration & dosage
- Prognosis
- Remission Induction
- Retrospective Studies
- Splenomegaly -- epidemiology
- Survival Analysis
- Translocation, Genetic
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't; Review; Validation Study
There are no comments on this title.
Log in to your account to post a comment.